Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00233883
Status:
COMPLETED
Last Update Posted:
2015-11-03
First Post:
2005-10-04
Brief Title:
WAND Study - A Study to Evaluate Fuzeon Enfuvirtide Administered by a Needle-Free Injection Device in Patients With HIV
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Study Overview
Official Title:
An Open-label Study of the Tolerability of a Subcutaneous Needle-free Injection Device Used to Administer Fuzeon Compared With the Standard NeedleSyringe Supplied With Commercial Fuzeon in HIV-1 Infected ARV Treatment-experienced Adults
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the tolerability of a subcutaneous needle-free injection device used to administer Fuzeon compared with the standard needlesyringe supplied with commercial Fuzeon The anticipated time on study treatment is 3 months and the target sample size is 100 individuals
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None